Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Genitourinary 1

Conditions

Sexuality 1Sexual Dysfunction, Physiological 1Radiation Injuries 1Prostatic Neoplasms 1Erectile Dysfunction 1

Interventions

Radiotherapy 24Radiotherapy, Intensity-Modulated 8Radiosurgery 6Amifostine 5Low-Level Light Therapy 4Donepezil 4Cisplatin 4Carboplatin 4Surveys and Questionnaires 3Radiation 3Proton Therapy 3Paclitaxel 3Neuropsychological Tests 3Heavy Ion Radiotherapy 3Etoposide 3Chemotherapy, Adjuvant 3Chemoradiotherapy 3Brachytherapy 3Bevacizumab 3Surgical Procedures, Operative 2Radiation Dose Hypofractionation 2Patient Reported Outcome Measures 2Mental Status and Dementia Tests 2Esophagectomy 2Androgen Antagonists 2Adrenal Cortex Hormones 2sodium propionate 1sargramostim 1olaparib 1endostar protein 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
OTHER × Radiation Injuries × ArginMax × Clear all
NCT01105130 2021-09-28

L-Arginine Supplementation With or Without Enzyme Inhibitors Treating Erectile Function of Prostate Cancer Survivors

Wake Forest University Health Sciences

Phase 2 Completed
140 enrolled 13 charts
Genitourinary

Erectile Dysfunction, Prostatic Neoplasms, Radiation Injuries

Data powered by HemOnc (CC BY 4.0) Colophon âš¡